STAT3 and vitiligo: Our study showed that LBP can down-regulate the ratio of p-STAT3/STAT3 in skin lesions of monobenzone-treated mice, suggesting that LBP may inhibit the activation of the STAT3-Hsp70-CXCL9/CXCL10 pathway in vitiligo treatment.